BRIEF — Biodesix Advances Two Complementary Approaches To Molecular Residual Disease (Mrd) Monitoring

Sept 24 (Reuters) — Biodesix Inc: Biodesix Advances Two Complementary Approaches To Molecular Residual Disease (Mrd) Monitoring Source text:... Further company coverage: BDSX.O (Reuters.Briefs@thomsonreuters.com;)